April 29, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Calix, Inc. (“Calix” or “the Company”) (NYSE: CALX). Investors who purchased Calix securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Calix has violated federal… read more
April 29, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating the merger between XOMA Royalty Corporation (“XOMA”) (NASDAQ: XOMA) and Ligand Pharmaceuticals Inc (“Ligand”) (NASDAQ: LGND). Investors who purchased XOMA and continue to hold to the present are encouraged to obtain additional information and assist the investigation. XOMA… read more
April 29, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Compass Therapeutics, Inc. (“Compass” or “the Company”) (NASDAQ: CMPX). Investors who purchased Compass securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Compass has violated… read more
April 29, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Spotify Technology S.A. (“Spotify” or “the Company”) (NYSE: SPOT). Investors who purchased Spotify securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Spotify has violated… read more
April 28, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating the merger between RE/MAX Holdings, Inc. (“RE/MAX”) (NYSE: RMAX) and The Real Brokerage Inc. (“The Real Brokerage”) (NASDAQ: REAX). Investors who purchased RE/MAX and continue to hold to the present are encouraged to obtain additional information and assist… read more
April 27, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Franklin BSP Realty Trust, Inc. (“FBRT” or “the Company”) (NYSE: FBRT). Investors who purchased FBRT securities prior to November 5, 2024, and continue to hold to the present, are encouraged to… read more
April 27, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Navan, Inc. (“Navan” or “the Company”) (NASDAQ: NAVN). Investors who purchased Navan securities prior to October 31, 2025, and continue to hold to the present, are encouraged to obtain additional information… read more
April 27, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nano-X Imaging Ltd. (“Nano-X” or “the Company”) (NASDAQ: NNOX). Investors who purchased Nano-X securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Nano-X has violated… read more
April 23, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of JinkoSolar Holding Co., Ltd. (“JinkoSolar” or “the Company”) (NYSE: JKS). Investors who purchased JinkoSolar securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether JinkoSolar has… read more
April 23, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sportradar Group AG (“Sportradar” or “the Company”) (NASDAQ: SRAD). Investors who purchased Sportradar securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Sportradar has violated… read more
April 23, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lakeland Industries, Inc. (“Lakeland” or “the Company”) (NASDAQ: LAKE). Investors who purchased Lakeland securities prior to December 1, 2023, and continue to hold to the present, are encouraged to obtain additional… read more
April 23, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ramaco Resources, Inc. (“Ramaco” or “the Company”) (NASDAQ: METC). Investors who purchased Ramaco securities prior to July 31, 2025, and continue to hold to the present, are encouraged to obtain additional… read more
April 23, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Chipotle Mexican Grill Inc (“Chipotle” or “the Company”) (NYSE: CMG). Investors who purchased Chipotle securities prior to February 8, 2024, and continue to hold to the present, are encouraged to obtain… read more
April 23, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Washington Trust Bancorp, Inc. (“Washington Trust” or “the Company”) (NASDAQ: WASH). Investors who purchased Washington Trust securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
April 21, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Badger Meter, Inc. (“Badger Meter” or “the Company”) (NYSE: BMI). Investors who purchased Badger Meter securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Badger… read more
April 21, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PicS N.V. a/ka PicPay Holdings (“PicPay” or “the Company”) (NASDAQ: PICS). Investors who purchased PicPay securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether PicPay… read more
April 21, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SunPower, Inc. (“SunPower” or “the Company”) (NASDAQ: SPWR). Investors who purchased SunPower securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether SunPower has violated federal… read more
April 21, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Select Medical Holdings Corp. (“Select Medical”) (NYSE: SEM). Investors who purchased Select Medical prior to March 2, 2026, and continue to hold to the present are encouraged to obtain additional information and assist the investigation…. read more
April 21, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating Forian Inc. (“Forian”) (NASDAQ: FORA). Investors who purchased Forian prior to April 2, 2026, and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/FORA. Forian… read more
April 21, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Veritone, Inc. (“Veritone” or “the Company”) (NASDAQ: VERI). Investors who purchased Veritone securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Veritone has violated federal… read more
April 21, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alstom S.A. (“Alstom” or “the Company”) (OTCMKTS: ALSMY; AOMFF). Investors who purchased Alstom securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Alstom has violated… read more
April 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of F5, Inc. (“F5” or “the Company”) (NASDAQ: FFIV). Investors who purchased F5 securities prior to October 28, 2024, and continue to hold to the present, are encouraged to obtain additional information… read more
April 19, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of RH (“RH” or “the Company”) (NYSE: RH). Investors who purchased RH securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether RH has violated federal securities… read more
April 19, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. (“Phreesia” or “the Company”) (NYSE: PHR). Investors who purchased Phreesia securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Phreesia has violated federal… read more
April 19, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. (“Phreesia” or “the Company”) (NYSE: PHR). Investors who purchased Phreesia securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Phreesia has violated federal… read more
April 16, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CarMax, Inc. (“CarMax” or “the Company”) (NYSE: KMX). Investors who purchased CarMax securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether CarMax has violated federal… read more
April 16, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ORIC Pharmaceuticals, Inc. (“Oric” or “the Company”) (NASDAQ: ORIC). Investors who purchased Oric securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Oric has violated… read more
April 16, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lucid Group, Inc. (“Lucid” or “the Company”) (NASDAQ: LCID). Investors who purchased Lucid securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Lucid has violated… read more
April 16, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lucid Group, Inc. (“Lucid” or “the Company”) (NASDAQ: LCID). Investors who purchased Lucid securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Lucid has violated… read more
April 16, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lucid Group, Inc. (“Lucid” or “the Company”) (NASDAQ: LCID). Investors who purchased Lucid securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Lucid has violated… read more